Press release
Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html
The “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides. The study also features a detailed analysis of key drivers and trends related to this evolving domain. Amongst other elements, the report includes:
A detailed review of the overall landscape of companies offering contract services for manufacturing of peptides.
An analysis on the recent developments in the industry, highlighting collaborations, facility expansions, and upcoming peptide synthesis technologies within this domain.
Informed estimates of the annual commercial and clinical demand for manufacturing peptides for therapeutic use.
A detailed analysis of more than 1,200 completed, ongoing and planned clinical trials of peptide therapeutics.
An estimate of the overall, installed capacity for manufacturing peptides, based on data reported by industry stakeholders in the public domain.
A discussion on regulatory guidelines related to peptide manufacturing, highlighting key differences across various geographies, various challenges, related to regulatory scrutiny, faced by peptide manufacturers.
Elaborate profiles of the key players that offer contract manufacturing services across different geographies, namely North America, Europe and Asia Pacific.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html
A discussion on industry affiliated trends, key drivers and challenges, under a SWOT framework.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Scale of Operation
Commercial
Preclinical / Clinical
Type of Peptide Synthesis Method Used
Chemical
Non-Chemical
Type of Peptide Chemical Synthesis Method Used
Liquid Phase Peptide Synthesis
Solid Phase Peptide Synthesis
Hybrid Phase Peptide Synthesis
Type of End User
Small sized CMOs
Mid-sized CMOs
Large and very large sized CMOs
Key Geographical Region
North America
Europe
Asia-Pacific and the Rest of the World
Transcripts of survey held with the following senior level representatives of stakeholder companies
Alastair Hay, Account Manager, Peptides, Almac
Philipp Burling, Chief Financial Officer, NUMAFERM
Hideki Kubota, Senior Manager, Peptide Business Project Leader, Sekisui XenoTech
Key companies covered in the report
AmbioPharm
Auspep
Bachem
BCN Peptide
Chinese Peptide
CordenPharma
CPC Scientific
Creative Peptides
CSBio
Hybio Pharmaceutical
PEPTIDE INSTITUTE
PolyPeptide Group
Senn Chemicals
Sinopharm Group
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html
Other Recent Offerings
1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030
2. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
3. Antibody Contract Manufacturing Market, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis here
News-ID: 2191207 • Views: …
More Releases from Roots Analysis
Modular Construction Market to Reach $202.04 Billion by 2035, Growing at 6.69% C …
The global modular construction market, valued at USD 105.73 billion in 2025, will grow to USD 155.94 billion by 2030 and reach USD 202.04 billion by 2035, advancing at a compound annual growth rate (CAGR) of 6.69% through the forecast period. This expansion reflects a broad structural shift in how governments, developers, and healthcare providers are commissioning buildings, as factory-built, modular methods prove faster, more cost-efficient, and more sustainable than…
Lab Automation Market to Reach USD 16.1 Billion by 2035, Growing at 9.5% CAGR | …
The global lab automation market, valued at USD 6.5 billion in 2025, is on track to reach USD 7.1 billion in 2026 and USD 16.1 billion by 2035, expanding at a compound annual growth rate of 9.5% over the forecast period 2026 to 2035, according to a new market intelligence report published by Roots Analysis. The market's expansion is driven by surging demand for biopharmaceutical development, a pressing need to…
Medical Aesthetics Market to Reach $102.3 Billion by 2035, Growing at 9.6% CAGR …
The global medical aesthetics market, valued at USD 37.6 billion in 2024 and projected to reach USD 40.9 billion in 2025, is on track to more than double to USD 102.3 billion by 2035, advancing at a compound annual growth rate (CAGR) of 9.6% over the 2025 to 2035 forecast period. Sustained demand for minimally invasive cosmetic procedures, a rapidly aging global population, and an accelerating pipeline of energy-based and…
Digital Twin Market to Reach $240.3 Billion by 2035, Growing at 30.54% CAGR | Si …
The global digital twin market, valued at $12.8 billion in 2024, is on course to reach $240.3 billion by 2035, expanding at a compound annual growth rate of 30.54% over the forecast period. This growth reflects a broad-based shift across industries toward real-time simulation, predictive intelligence, and virtual prototyping as organizations look to reduce operational costs and accelerate decision cycles. The scale and pace of this expansion signal that digital…
More Releases for Peptide
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg
Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity.
This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
